Acumen Pharmaceuticals (ABOS) Earnings Date & Reports

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABOS is expected to report earnings to rise 8.88% to -35 cents per share on August 17

Acumen Pharmaceuticals ABOS Stock Earnings Reports

Q2'26

Est.

$-0.36

Q1'26

Beat

by $0.04

Q4'25

Beat

by $0.06

Q3'25

Beat

by $0.16

Q2'25

Missed

by $0.17

The last earnings report on May 12 showed earnings per share of -33 cents, beating the estimate of -37 cents. With 160.14K shares outstanding, the current market capitalization sits at 172.26M.

View a ticker or compare two or three

Compare

ABOS

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ABOS